You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brenner Tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

Completed
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Los Angeles, California
  • +48 more
Dec 2, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,

Completed
  • Brenner Tumor
  • +11 more
  • adjuvant therapy
  • +3 more
  • Orange, California
  • +18 more
Jul 19, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma Trial in United States (carboplatin, paclitaxel, docetaxel)

Completed
  • Brenner Tumor
  • +12 more
  • Orange, California
  • +15 more
Jul 19, 2019

Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

Not yet recruiting
  • Digestive Tumor
  • TM4SF1-positive chimeric antigen receptor T-cell therapy
  • (no location specified)
Dec 21, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Active, not recruiting
Has Results
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Clinical Observation
  • +4 more
  • Birmingham, Alabama
  • +314 more
Sep 28, 2021

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma

Active, not recruiting
Has Results
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +29 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +572 more
Jan 28, 2023

Prostate Cancer Trial in Baltimore (hypofractionation)

Active, not recruiting
  • Prostate Cancer
  • hypofractionation
  • Baltimore, Maryland
    The Johns Hopkins University School of Medicne
Mar 18, 2022

Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

Completed
  • Sarcoma
  • +3 more
  • Anti-GD2-CAR engineered T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

Recruiting
  • Colorectal Neoplasms
  • Gilbert, Arizona
  • +46 more
Jan 31, 2023

Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

Recruiting
  • Newly Diagnosed Glioblastoma
  • SurVaxM
  • San Francisco, California
  • +9 more
Aug 23, 2022

Malignant Tumor Trial in Chendu (EBV immunological agent)

Recruiting
  • Malignant Tumor
  • EBV immunological agent
  • Chendu, Sichuan, China
    West China Hospital
Jan 31, 2023

Advanced Solid Tumor Trial in United States (XTX202)

Recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
  • +4 more
Jul 21, 2022

Relapsed or Refractory B-cell Lymphoma Trial in Guangzhou (infusion of JY231 injection)

Recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • infusion of JY231 injection
  • Guangzhou, Guangdong, China
    Guangdong Second Provincial General Hospital
Sep 17, 2023

Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)

Recruiting
  • Glioma
  • Rhenium Liposome Treatment
  • Dallas, Texas
  • +2 more
Nov 3, 2021

Children With Medical Complexity Trial in Winston-Salem (Interagency Collaboration (ICollab), Usual Care)

Recruiting
  • Children With Medical Complexity
  • Interagency Collaboration (ICollab)
  • Usual Care
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Dec 22, 2022

Weight Loss, Pediatric Obesity, Overweight Adolescents Trial in Winston-Salem (Brenner FIT Standard, By Design Essentials, Dyad

Recruiting
  • Weight Loss
  • +4 more
  • Brenner FIT Standard
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Medical Center
May 26, 2022

PET/CT Parameters and Tumor Markers in Recurrent Breast Cancer

Not yet recruiting
  • Breast Cancer
  • PET/CT
  • (no location specified)
Sep 30, 2021

l, Laboratory and Epidemiologic Characterization of Individuals

Completed
  • Familial Ovarian Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 31, 2022

    Pancreas Cancer Trial in Jinan (Sintilimab Plus mFFN and Radiation)

    Recruiting
    • Pancreas Cancer
    • Sintilimab Plus mFFN and Radiation
    • Jinan, Shandong, China
      Department of Radiation Oncology, Shandong Cancer Hospital and I
    Sep 21, 2023